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Abstract 
We examined several aspects of glucose transport reconstituted in liposomes, with emphasis on transporters of rat heart 
(mostly GLUT4) compared to those of human erythrocytes (GLUT1), and on effects of agents that modulate transport in 
intact cells. Several types of samples gave higher reconstituted activity using liposomes of egg lipids rather than soybean 
lipids. Diacylglycerol, proposed to activate transporters directly as part of the mechanism of insulin action, increased the 
intrinsic activity of heart transporters by only 25%, but increased the size of the reconstituted liposomes by 90%. The 
dipeptide Cbz-Gly-Phe-NH2 inhibited GLUT4 with a Ki of 0.2 mM, compared to 2.5 mM for GLUT1, which explains its 
preferential inhibition of insulin-stimulated glucose transport in adipocytes. Verapamil, which inhibits insulin- and hypoxia- 
stimulated glucose transport in muscle, had no effect on reconstituted transporters. Heart transporters had a higher Km for 
glucose uptake (13.4) than did GLUT1 (1.6 mM), in agreement with a recent study of GLUT1 and GLUT4 expressed in 
yeast and reconstituted in liposomes. Transporters reconstituted from heart and adipocytes were 40-70% inactivated by 
external trypsin, suggesting the presence of trypsin-sensitive sites on the cytoplasmic domain of GLUT4. NaC1 and KC1 both 
reduced reconstituted transport activity, but KC1 had a much smaller effect on the size of the liposomes. © 1998 Elsevier 
Science B.V. All rights reserved. 
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1. Introduction 
Reconstitution of transport proteins in liposomes 
is a useful technique for studying certain aspects of 
their kinetics and regulation apart from possible 
complicating factors found in intact cells. Previously 
we have used reconstitution by the freeze-thaw pro- 
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cedure [1] to study kinetics of the human erythrocyte 
glucose transporter [2,3]. We have also used the tech- 
nique to examine compounds proposed to interact 
directly with glucose transporters of erythrocytes [4] 
and rat adipocytes [5]. In the experiments described 
here, we examined several aspects of the kinetics and 
regulation of glucose transporters, focusing on insu- 
lin-sensitive tissues (especially the heart). The major 
transporter isoform of these tissues is GLUT4. The 
results are compared to those obtained with the 
erythrocyte transporter (GLUT1). 
The effects of two variables (lipids and salts) on 
the freeze-thaw reconstitution process were also ex- 
amined. We show how a combination of measure- 
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ments can help distinguish direct effects on transport- 
ers from effects on the reconstitution, a method 
which may be of general applicability. 
In these experiments, we have employed an ap- 
proach in which liposomes are reconstituted at low 
ratios of protein to lipid, such that reconstituted lip- 
osomes have at most one transporter. This approach 
was discussed by Gorga and Lienhard [6], and used 
in our previous studies [3-5,7]. As described in [6], 
'Second, inasmuch as each vesicle contains either 
only one or no functional transporters, the fraction 
of the total intravesicular volume that rapidly equi- 
librates with substrate in the medium provides a 
measure of the number of functional transporter 
molecules. Third, because ach rapidly equilibrating 
vesicle contains only one transporter molecule, the 
rate of substrate equilibration provides a measure 
of the intrinsic activity of the transporter'. 
Thus, a change in the intrinsic activity of reconsti- 
tuted transporters alters the stereospecific glucose up- 
take at early times, but not the total stereospecific 
uptake measured at later times, which depends only 
on the number of functional transporters (Fig. 2A of 
[6]). Conversely, a change in the number of reconsti- 
tuted transporters affects the maximum stereospecific 
uptake, but not the fraction of this uptake which is 
achieved at early times (Fig. 2B of [6]). 
Because we were interested in possible effects on 
the size distributions of the liposomes, we also meas- 
ured the total internal volume. For this purpose we 
assayed the uptake of L-glucose in 24 h, whereas 
Gorga and Lienhard [6] measured xylitol uptake in 
lh .  
In many of the experiments described below, we 
measured the zero-trans uptake of 0.2 mM glucose, a 
concentration well below the Kin. Under these con- 
ditions, the rate of equilibration is proportional to 
VmaxIKm. Thus, changes in this rate reflect changes in 
the catalytic efficiency (defined as Vmax/(Km ×number 
of transporters)) rather than measuring directly the 
turnover number (Vmax/number of transporters). De- 
termination of Vmax is technically much more diffi- 
cult because as the concentration of glucose is in- 
creased, the ratio of non-specific permeation to 
stereospecific transport increases. While the measure- 
ments at 0.2 mM glucose in themselves do not allow 
us to distinguish effects on Vma~ from those on Km, 
this can be determined by additional measurements 
at various glucose concentrations (e.g., Fig. 3 of [5]). 
Moreover, changes in the catalytic efficiency of the 
transporter in response to physiological events would 
affect glucose transport at subsaturating glucose lev- 
els, and thus be of interest regardless of whether they 
arise from changes in Km or Vmax. 
2. Materials and methods 
2.1. Materials 
D-[14C]Glucose was obtained from ICN and 
L-[1-3H]glucose from Dupont NEN. Phospholipids, 
diacylglycerols, TPCK-treated trypsin, Cbz-Gly- 
Phe-NH2, and verapamil were from Sigma. Human 
erythrocyte membranes were prepared by the method 
of Dodge et al. [8] using outdated erythrocytes do- 
nated by the American Red Cross (Louisville, KY). 
Alkaline-washed vesicles [9], Triton extracts [9] and 
purified transporters [2,9] were prepared from these 
membranes as described. Membrane fractions from 
rat adipocytes were a gift of Dr. Samuel Cushman. 
Bovine heart plasma membranes [7] and rat heart 
high-speed pellet membranes [10] were prepared as 
described. 
2.2. Reconstitution and assay of glucose transport 
activity 
Liposomes were prepared from soybean phospha- 
tidylcholine (Sigma type II-S) or from egg PC (type 
IX-E or XV-E). The lipids were suspended in 10 mM 
Tris-HCl, pH 7.4, at 50 or 150 mg/ml and sonicated 
in a bath-type sonicator until an apparent maximum 
clarity had been achieved. In experiments with 
diacylglycerols, the DAG was included along with 
the phospholipids in the preparation of the 
liposomes. 
Membrane proteins were reconstituted without 
prior detergent treatment, after dispersal with 0.3% 
cholate or solubilization with 1.5% cholate [7], or 
after solubilization with 0.5% Triton X-100 [9]. Fol- 
lowing centrifugation of detergent-treated samples, 
the cholate and Triton were removed by gel filtration 
or by Bio-Beads SM-2, respectively. 
Mixtures of liposomes (25 mg lipid/ml) and mem- 
brane proteins (0.1 or 0.2 mg protein/ml) were frozen 
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in liquid nitrogen and allowed to thaw at room tem- 
perature. The samples were then subjected to sonica- 
tion using either a bath sonicator (for 5 s) or a probe 
sonicator (Branson model 200 with microtip). For 
the probe sonicator, the optimum sonication power 
and time were found to vary with the particular 
microtip and how long it had been in use; typi- 
cally, settings of 3.0 or 3.5 and times of 4-8 s were 
used. 
Glucose uptake into the liposomes was measured 
using filtration assays as described [7], with D- 
[14C]glucose used to measure total glucose uptake 
and tracer L-[3H]glucose used to correct for non-spe- 
cific uptake. For most experiments, the zero-trans 
uptake of 0.2 mM D-glucose was measured. In 
some cases, zero-trans uptake of glucose at various 
other concentrations was measured. For measure- 
ment of equilibrium exchange, liposomes were recon- 
stituted in the absence of glucose, then equilibrated 
with non-radioactive glucose. Assays were initiated 
by the addition of radioactive glucose at the same 
concentration [2]. For experiments with salts, the 
salts were included at the indicated concentrations 
during the initial preparation of the liposomes, the 
reconstitution, and the assays. For experiments with 
Cbz-Gly-Phe-NH2 and verapamil, the compounds 
were added at the initiation of the assays. For experi- 
ments with trypsin, the enzyme was added after re- 
constitution but at least 20 min before the assays. 
For all experiments, the osmolarity of the stopping 
solution (containing 0.5 mM HgC12, and kept on ice) 
was adjusted with NaC1 or KC1 to equal the osmo- 
larity of the assay solutions. 
Previously we [7] and others [11] noted that pro- 
tein-free liposomes of egg lipids took up a small ex- 
cess of D-glucose over L-glucose. This excess D-glu- 
cose uptake was subtracted before calculation of 
stereospecific uptake due to reconstituted glucose 
transporters. Control experiments were performed 
to determine the appropriate corrections for the 
range of experimental conditions encountered in 
this study: for various time points up to 30 min; 
for liposomes of soybean as well as of egg lipids; 
for various salt concentrations; and for two different 
preparations of D-[14C]glucose (catalog Nos. 11047 
and 11050, having radiochemical purities of 99.5% 
and 96%, respectively). 
2.3, Calculation of effects of diacylglycerol and salts 
on intrinsic activity, reconstitution efficiency, and 
liposome volume 
In order to assess the effects of agents which were 
present throughout the reconstitution and assays, the 
following model was employed. An agent might af- 
fect the intrinsic activity of reconstituted transport- 
ers, the efficiency with which transporters are recon- 
stituted in an active state, and the average internal 
volume of reconstituted liposomes. The effects of the 
agent on these parameters, relative to control lipo- 
somes, are designated a, b, and c, respectively. As 
noted in Section 1, at the low glucose concentration 
employed (0.2 mM), changes in the intrinsic activity 
could arise from changes in Vma× and/or Kin. 
Experimentally, the effects of the agents on the 
initial rate of stereospecific uptake (estimated at 30 
s), the maximum stereospecific uptake (estimated at 
30 min), and the total internal iposome volume (es- 
timated from the uptake of L-glucose in 24 h) were 
measured. The effect on the L-glucose uptake was 
used as the value of c, based on the assumption 
that the effect on the sizes of liposomes containing 
transporters i  similar to the effect on the total pop- 
ulation of liposomes. The effect on the initial rate of 
uptake was assumed to be the product of the effects 
on the intrinsic activity and reconstitution efficiency, 
or ab. The effect on the maximum stereospecific up- 
take (when liposomes containing transporters have 
equilibrated external and internal D-glucose, but 
have taken up relatively little L-glucose) was assumed 
to be the product of the effects on the reconstitution 
efficiency and liposome volume, or bc. 
The values of ab, bc, and c were averaged over all 
experiments. The average value of bc was divided by 
the average value of c to yield b, the effect on the 
reconstitution efficiency. For the experiments with 
diacylglycerol, the ratio of the 30 s uptake to 30 
min uptake (which gives ab/bc, or a/c) was also de- 
termined in each experiment, and then averaged over 
all experiments. This ratio was then multiplied by the 
average value of c to yield a, the effect on the intrin- 
sic activity. For experiments with salts, in which 
there were fewer experiments in which both the 30 
s and 30 min uptakes were measured, b was deter- 
mined as described, and the average value of ab was 
divided by this to yield a. 
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Table 1 
Reconstitution of glucose transporters in liposomes of egg or soybean lipids 
Sample Stereospecific uptake (~tl/(mg ×2 min)) Relative uptake (egg lipids/soybean lipids) 
Egg lipids Soybean lipids Stereospecific Non-specific 
Rat heart HSP 
Untreated (7) 3.7 (27) 7.6 (41) 0.49 + 0.10 0.64 + 0.19 
Cholate-dispersed (7) 15.1 (53) 8.5 (40) 1.87 + 0.17 1.03 + 0.06 
Bovine heart PM 
Untreated (3) 8.6 (55) 8.3 (57) 1.01 + 0.23 0.80 + 0.28 
Cholate-dispersed (4) 12.7 (63) 8.8 (26) 1.66 + 0.40 0.62 + 0.35 
Cholate-solubilized (8) 10.9 (42) 5.5 (22) 2.10 + 0.20 0.70 + 0.13 
Rat adipocyte HSP 
Untreated (3) 8.7 (30) 15.1 (34) 0.59 + 0.13 0.62 + 0.02 
Cholate-dispersed (3) 13.3 (47) 14.0 (26) 1.00 + 0.19 0.27 + 0.11 
Human erythrocytes 
Ghosts, untreated (5) 144 (87) 101 (73) 1.38 + 0.11 0.70 + 0.25 
Alkaline-washed vesicles, untreated (3) 405 (88) 315 (77) 1.38 + 0.08 0.72 + 0.10 
Alkaline-washed vesicles, Triton-solubilized (4) 160 (84) 80 (50) 2.06 + 0.37 0.44 + 0.04 
Purified transporter (3) 435 (85) 392 (85) 1.08 + 0.09 1.10 + 0.13 
Liposomes were prepared from either egg lipids (Sigma phosphatidylcholine type IX-E) or soybean lipids (Sigma phosphatidylcholine 
type II-S), and reconstituted with the indicated type of sample. Total (D-glucose), non-specific (L-glucose), and stereospecific (D- minus 
L-glucose) uptake of 0.2 mM glucose in 2 rain were measured. Results are expressed as absolute uptakes (in Ixl equilibrated with the 
external solution) in the first two columns, and as relative uptakes (+ S.E.) in the last two columns. Figures in parentheses next to the 
samples indicate the number of experiments. Figures in parentheses in the first two columns indicate the percentage of total uptake 
which was stereospecific. 
3. Results 
3.1. Comparison of reconstitutions u ing two types 
of lipids 
In a study of reconstituted adipocyte glucose 
transporters, Robinson et al. [11] found a 2-fold 
higher activity using liposomes of egg lipids (phos- 
phatidylcholine type IX-E from Sigma) rather than 
soybean lipids (PC type II-S). Since our previous 
reconstitution studies [2-4,7,12] had used soybean 
lipids, we tested for a similar enhancement of activity 
with egg lipids. In the experiments summarized in 
Table 1, samples were reconstituted into liposomes 
of the two types; the relative uptake (egg/soybean) 
was determined for samples reconstituted in the same 
experiment. The stereospecific uptake of 0.2 mM glu- 
cose was measured in 2 min. At this time it has 
reached 50-100% of its maximum value, and changes 
only slowly with time (Fig. 1 [3] and Fig. 2 [7]). Thus, 
changes in the intrinsic activity of the transporter will 
have relatively little effect on the uptake. However, 
the uptake will be directly proportional to the recon- 
stitution efficiency, and nearly proportional to the 
internal volume of the liposomes. 
Previously we [3,7,12] and others [13,14] had 
shown that transport can be reconstituted using 
membranes without prior detergent treatment, be- 
cause the freeze-thaw procedure [1] results in fusion 
of protein-lipid vesicles with liposomes. Table 1 in- 
cludes results obtained for untreated erythrocyte 
ghosts, rat heart and adipocyte HSP membranes, 
and bovine heart plasma membranes. It also includes 
results with membranes subjected to detergent treat- 
ment. For heart and adipocyte samples, 'cholate-dis- 
persed' membranes were treated with low concentra- 
tions of cholate and the supernatants from 15 000 × g 
centrifugations were reconstituted [7,11], while 'cho- 
late-solubilized' membranes were treated with higher 
concentrations of cholate and the supernatants from 
100 000 × g centrifugations were reconstituted [7]. In 
both cases cholate was removed by gel filtration be- 
fore reconstitution. Finally, Table 1 includes results 
from stages of the purification of the human eryth- 
rocyte transporter [2]: alkaline-washed vesicles, a 
Triton extract of the vesicles (with Triton removed 
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by Bio-Beads prior to reconstitution), and the puri- 
fied transporter. 
Depending upon the type of sample, sometimes 
egg lipids and sometimes soybean lipids gave higher 
activity. However, for each type of membrane, the 
ratio of stereospecific uptake using egg lipids to that 
using soybean lipids (third column) was higher for 
detergent-treated samples than for untreated mem- 
branes. In addition, the non-specific uptake was, 
for most samples, significantly lower for egg lipids 
(fourth column). 
For cholate-treated heart membranes, both bovine 
and rat, the egg lipids gave about 2-fold higher ac- 
tivity. This enhancement was explored further using 
cholate-solubilized bovine heart membrane proteins. 
When the time courses of stereospecific uptake were 
compared, it was found that the ratio was initially 
low (1.25 at 30 s) but increased with time (to 2.5 at 
20 min). These experiments were performed at low 
ratios of protein to lipid, such that most liposomes 
should have at most one transporter [3,7]. Under 
these conditions the initial rate of uptake is propor- 
tional to the product of the number of transporters 
reconstituted and their intrinsic activity, while the 
final extent of uptake is determined by the number 
of transporters reconstituted and the internal vol- 
umes of liposomes containing transporters. The larg- 
er effect on the final than on the initial uptake sug- 
gests that the major effect was on the liposome size, 
with about 2-fold larger volumes being produced 
with egg lipids. However, in two experiments using 
reconstituted erythrocyte ghost proteins, the initial 
rate of glucose uptake was 2-fold higher using egg 
lipids. This indicates an effect on the intrinsic activity 
and/or reconstitution efficiency. Since the uptake in 
2 min (which is relatively insensitive to changes in the 
intrinsic activity) is also higher in egg lipids (Table 
1), the latter appears more likely. 
In most of the experiments described below, we 
employed cholate-dispersed heart membrane proteins 
reconstituted using egg lipids. In a few of these ex- 
periments, the lipids were a different catalog listing 
(Sigma type XV-E) which replaced that used for the 
experiments of Table 1 (type IX-E). The particular 
lot (038F71651) of type XV-E used in these experi- 
ments gave activities about 20-30% lower than the 
type IX-E when the two were compared using rat 
heart HSP membranes. However, two other lots 
(80H7125 and 90H7115) gave unacceptably ow ac- 
tivity with reconstituted heart transporters. Previ- 
ously we had reported variations among activities 
obtained using different lots of soybean lipids (type 
II-S) [7]. The comparisons in Table 1 were made 
using the lots of both egg and soybean lipids which 
yielded the highest ransport activity. 
3.2. Effects of diacylglycerol 
An early event in insulin action on muscle and 
adipose tissue is an increase in diacylglycerol. Strfd- 
fors [15] showed that exogenous diacylglycerols could 
stimulate glucose uptake 6-fold in rat adipocytes. 
The stimulation appeared to be due neither to trans- 
location of glucose transporters nor to activation of 
protein kinase C. This suggested a direct effect of 
DAG on the intrinsic activity of glucose transporters. 
A direct effect was also suggested as an explanation 
of the results of Standaert et al. [16], who observed 
stimulation of deoxyglucose uptake in BC3H-1 my- 
ocytes by exogenous dioctanoylglycerol. 
If an effect of DAG on the intrinsic activity of 
glucose transporters i important in insulin action, 
it would have to be on GLUT4, the major isoform 
in plasma membranes of insulin-stimulated cells. We 
tested the effects of DAG on the activity of recon- 
stituted rat heart HSP glucose transporters (also 
mostly GLUT4). Most of these experiments em- 
ployed dimyristoylglycerol (ditetradecanoylglycerol), 
the most stimulatory of the diacylglycerols tested by 
Str~dfors [15]; as in that study, a racemic mixture of 
sn-l,2 and sn-2,3 enantiomers was used. 
We incorporated diacylglycerols into the liposomes 
by adding them to the phospholipids during the ini- 
tial sonication step, and observed a stimulation of 
initial rates. However, this could result not only 
from an increase in the intrinsic activity of the recon- 
stituted transporters, but also from an increase in the 
number of transporters econstituted (reconstitution 
efficiency). We resolved these by measuring the ef- 
fects of DAG on not only the initial rate of uptake 
(estimated from the uptake in 30 s), but also on the 
maximum stereospecific volume (estimated from the 
uptake in 30 min) and on the total liposome volume 
(estimated from the L-glucose uptake in 24 h). 
Results obtained using dimyristoylglycerol and egg 
lipids are shown in Fig. 1A. For all three determina- 
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tions the effect reached a maximum at about 4% 
DMG. The initial rate of uptake (filled circles) was 
increased by about 30% at 1 or 2% DMG and by an 
average of 43% at 4-8% DMG. There was a much 
larger effect on the stereospecific volume (open 
circles), which was increased an average of about 
90% at 4-8% DMG. The total liposome volume (tri- 
angles) was also increased, by an average of about 
65% for 4-8% DMG. 
These data were analyzed as described in Section 2 
with the results shown in Fig. lB. The major effect of 
DMG appears to be on the liposome volume, which 
increased as much as 65%. The reconstitution effi- 
ciency was affected very little (an average increase 
of 15% for 4-8% DMG). Finally, the intrinsic activ- 
ity was increased slightly; this effect appeared max- 
imal at 1% DMG, and averaged 27% over the range 
of 1-8% DMG. 
We also varied the liposome lipids and the acyl 
chain of the DAG. The effects of DMG on the 30 
s and 30 min stereospecific uptake were determined 
using soybean rather than egg lipids. In two experi- 
ments each at 2% and 3% DMG, the effects were 
similar to those obtained with egg lipids (data not 
shown). Effects of dipalmitoylglycerol, which was 
much less stimulatory than DMG in the study of 
Strfilfors [15], were tested using egg lipids. Two ex- 
periments each determined the effects of 1% and 2% 
dipalmitoylglycerol on the 30 s and 30 min uptake; 
these were similar to the effects of DMG (data not 
shown). While these two sets of experiments did not 
address whether the variations in liposome composi- 
tion or acyl chain affected the liposome volume (the 
parameter most affected by DMG), they suggest that 
neither variation had a large effect on the intrinsic 
activity. 
3.3. Effects of dipeptide 
Aiello et al. [17] reported that the dipeptide Cbz- 
Gly-Phe-NH2 inhibited insulin-stimulated glucose 
transport more strongly than basal transport in adi- 
pocytes. We found that the dipeptide inhibited adi- 
pocyte glucose transporters after reconstitution, indi- 
cating that it acts directly on the transporter [5]. 
Reconstituted human erythrocyte transporters were 
also inhibited, with 50% inhibition seen between 1.5 
and 2 mM ([5], Fig. 2). The inhibition was not re- 
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Fig. 1. Effects of dimyristoylglycerol n reconstituted rat heart 
HSP glucose transporters. Liposomes were prepared from egg 
lipids containing the indicated concentration of dimyristoylgly- 
cerol, and reconstituted with cholate-dispersed rat heart HSP 
membrane proteins. (A) Observed effects: e, initial rate of ster- 
eospecific uptake of 0.2 mM glucose, estimated from uptake at 
30 s; ©, total stereospecific uptake, estimated from uptake at 
30 min; A, total liposome volume, estimated from uptake of L- 
glucose in 24 h. Results were normalized to control liposomes 
in the same experiments, and are means_+ S.E. from three to 
five experiments. (B) Calculated effects: e, intrinsic activity; ©, 
reconstitution efficiency; A, liposome volume (same data as in 
A). Some points have been offset with respect o the x-axis for 
clarity. 
duced by increasing concentrations of glucose ([5], 
Fig. 3). 
We tested the effects of the dipeptide on glucose 
transport by reconstituted heart HSP membrane pro- 
teins; results are shown in Fig. 2 (solid circles). A fit 
of these data gave a maximum inhibition of 71 _+ 6% 
and a Ki of 0.20 __ 0.05 mM (solid line). The broken 
line in Fig. 2 is a fit to data for reconstituted eryth- 
rocyte membrane proteins, using both the results 
shown in Fig. 2 of [5] and additional determinations. 
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The parameters of  this fit are 123 + 24% for the max- 
imum inhibition and 2.5 + 0.8 mM for Ki. 
We considered the possibility that the heart data 
arose f rom a major  component  (GLUT4)  with a low 
Ki and a minor component  (GLUT1)  with a higher 
Ki. Assuming that both components could be inhib- 
ited 100% and that GLUT1 had a Ki of  2.5 mM,  as 
observed for erythrocyte transporters, a fit to the 
data gave similar amounts of  the two isoforms and 
a Ki of  0.12+0.05 mM for GLUT4.  Alternatively, 
assuming that 79% of the transporters are GLUT4 
[18] and that GLUT1 had a max imum inhibition of 
100% and a Ki of  2.5 mM,  a fit gave a max imum 
inhibition of  63% and a Ki of  0.17+0.06 mM for 
GLUT4.  Both of  these fits gave curves very similar 
to the solid line in Fig. 2. 
3.4. Effects of verapamil 
Cartee et al. [19] observed that verapamil  at 10- 
200 gM inhibited insulin- or hypoxia-st imulated 3-0-  
methylglucose transport by rat skeletal muscle. Both 
(+)- and ( - ) -verapami l  were equally effective, indi- 
cating that the effect was not due to blocking of Ca 2-- 
channels, and suggesting that it could be a direct 
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Fig. 2. Inhibition of stereospecific glucose uptake by dipeptide. 
Liposomes were reconstituted with cholate-dispersed rat heart 
HSP membrane proteins, or with human erythrocyte membrane 
proteins. Stereospecific uptake of 0.2 mM glucose in 30 s was 
determined in the presence of the indicated concentrations of 
Cbz-Gly-Phe-NH2. o, heart HSP proteins. Results are means 
+ S.E. for three to eight determinations. The solid line indicates 
a fit of these data (maximum inhibition = 71%, Ki =0.20 raM). 
The dashed line is a fit to erythrocyte membrane protein data 
from [5], plus additional determinations (maximum inhibi- 
tion= 123%, Ki =2.5 mM). 
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Fig. 3. Zero-trans uptake by reconstituted heart and erythrocyte 
transporters. Cholate-dispersed rat heart HSP membrane pro- 
teins (A) or untreated human erythrocyte membrane proteins 
(B) were reconstituted into liposomes of egg lipids. Initial rates 
of stereospecific glucose uptake at the indicated glucose concen- 
trations were estimated from the uptake in 30 s (A) or 20 s (B). 
Data are from two experiments for each type of sample, which 
are indicated by filled or open circles. Some points in A have 
been offset with respect o the x-axis for clarity. The curves are 
drawn to non-linear egression fits of the data to the Michaelis- 
Menten equation: (A) Km = 13.4 + 1.8 mM, Vma x -- 4.2 + 0.6 nmol/ 
(sxmg); (B) Km -- 1.6+0.3 mM, Vmax = 9.8+ 1.1 nmol/(sxmg). 
inhibition of GLUT4.  We tested the effects of vera- 
pamil on the initial rate of glucose transport by re- 
constituted rat heart HSP membrane proteins. In 
seven determinations at 300 or 1000 ~tM verapamil, 
we observed insignificant (5 + 10%) inhibition. Glu- 
cose transport  by reconstituted erythrocyte mem- 
brane proteins also was not significantly inhibited 
by 200-1000 ~tM verapamil  (9 + 4% inhibition, n = 4). 
3.5. Net and exchange uptake by reconstituted heart 
transporters 
It was of interest o compare the kinetic features of  
the reconstituted rat heart HSP transporters (mostly 
GLUT4)  to those of the reconstituted human eryth- 
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rocyte transporter (GLUT1), which we had previ- 
ously characterized [2]. Fig. 3A shows initial rates 
of transport under zero-trans conditions for heart 
transporters reconstituted using egg lipids. A fit to 
the data gave a Km of 13.4+ 1.8 mM, much higher 
than the value of 1.2 mM observed for the purified 
erythrocyte ransporter [2]. To ensure that this differ- 
ence did not arise from the use of egg lipids rather 
than soybean lipids (used in [2]) we also tested eryth- 
rocyte membrane proteins reconstituted using egg 
lipids (Fig. 3B). These data gave a Km of 1.6 +0.3 
mM, in good agreement with the earlier result. 
Fig. 4 shows the rates of glucose transport cata- 
lyzed by reconstituted heart proteins under equili- 
brium exchange conditions. The Km was 62+23 
mM, much higher than for zero-trans uptake. Previ- 
ously we determined an exchange Km of 35 mM for 
the reconstituted erythrocyte transporter [2]. 
The results shown in Figs. 3A and 4 indicate that 
at high glucose concentrations, the reconstituted 
heart transporters have higher rates for exchange 
than for net flux (exchange acceleration). In addition, 
two experiments with reconstituted adipocyte HSP 
transporters (also mostly GLUT4) yielded 2.4- and 
1.9-fold higher initial rates for exchange than for net 
uptake of 20 mM glucose. This is in contrast o 3-0- 
methylglucose transport in insulin-stimulated a ipo- 
cytes, where zero-trans uptake and equilibrium ex- 
change have similar kinetic parameters (e.g., [20]), 
and zero-trans ettlux is faster than exchange [21,22]. 
Previously we noted that the reconstituted erythro- 
cyte transporter displayed more exchange accelera- 
tion than intact erythrocytes [2]. Thus, reconstituted 
GLUT1 and GLUT4 both had greater than expected 
exchange acceleration. We were concerned that this 
might be an artifact of osmotic effects, since at the 
beginning of the zero-trans uptake assays the lipo- 
somes encounter an osmotic gradient which should 
make them shrink. 
We therefore tested the effects of osmolarity on the 
exchange acceleration. Liposomes were prepared and 
assayed in either the usual buffer (10 mM Tris-HC1) 
or in buffer to which salt was added, reducing the 
osmotic gradient present at the beginning of zero- 
trans assays. For the rat heart transporters, the ex- 
change acceleration was measured at 20 mM glucose 
with no salt, or with 5 or 10 mM NaC1 or 20 mM 
KC1 added. The average ratio of initial rates (ex- 
6 
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Fig. 4. Equilibrium exchange uptake by reconstituted rat heart 
transporters. Samples were reconstituted and assayed as in Fig. 
3A, except that the liposomes were preincubated with the indi- 
cated concentrations of non-radioactive D-glucose. Three experi- 
ments were performed. In one the reconstituted activity was 
higher than in the other two, so the data were normalized to 
the mean rate obtained at 2 mM glucose, and the resulting 
means (+ S.E.) are plotted. For the 5 and 20 mM points, the 
error bars lie within the diameters of the symbols. The data 
were then fit as for Fig. 2, with the line drawn to the resulting 
parameters (Km = 62 + 23 mM, Vmax = 10.9 + 3.4 nmol/(s × mg)). 
change/net) decreased from 2.58 + 0.28 (mean + S.E., 
n = 9) with no added salt to 2.31 + 0.28 (n = 4) with 10 
mM NaC1 added and 1.54 + 0.22 (n = 3) with 20 mM 
KCI added. These data were extrapolated to infinite 
osmolarity by plotting the ratios vs. the reciprocals 
of the osmolarities. A linear regression fit gave an y- 
intercept of 1.44, suggesting that much of the accel- 
erated exchange observed in the absence of salt is 
due to osmotic effects. 
For erythrocyte transporters, two experiments 
were performed in which the exchange acceleration 
was measured at 5 mM glucose (since the Km for net 
flux is much lower than for the heart transporters, 
exchange acceleration can be observed at lower glu- 
cose concentrations). The ratio of exchange to net 
uptake was actually higher in the presence (3.3- 
and 3.9-fold) than in the absence (2.9- and 2.8-fold) 
of 20 mM KC1, although the differences were not 
statistically significant. Thus, in this case it appears 
that osmotic effects are not responsible for the higher 
than expected egree of exchange acceleration. 
3.6. Effects of  trypsin 
Addition of trypsin after reconstitution decreases 
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the activity of  the human erythrocyte transporter by 
about 40-50% [2,3]. This was consistent with inacti- 
vation at the cytoplasmic domain [23] and a scram- 
bling of orientations in the reconstituted liposomes, 
such that about  half  of  the transporters had this 
domain exposed on the external surface. We meas- 
ured the effects of trypsin treatment on reconstituted 
transporters f rom HSP membranes of rat heart and 
adipocytes (Table 2). For  both cell types the uptake 
was reduced by trypsin treatment, with the adipocyte 
transporters being more sensitive. 
3.7. Effects o f  NaCl and KCl 
Because addition of  high concentrations of  sugars 
to reconstituted l iposomes could cause problems due 
to osmotic shrinking, we explored carrying out the 
reconstitution and assays in the presence of added 
salt to minimize osmotic effects. Fig. 5 shows the 
effects of  NaC1 and KCI  on reconstituted heart and 
erythrocyte transporters. Effects on the initial rates, 
the max imum stereospecific uptakes, and the lipo- 
some volumes were determined. For  heart transport- 
ers reconstituted using egg lipids, all three of  these 
measures decreased with increasing salt concentra- 
tion; however, the decreases were much larger for 
added NaCI  than for added KC1. We resolved these 
effects into effects on the intrinsic activity, reconsti- 
tution efficiency, and l iposome volume as for the ex- 
periments with DAG (Fig. 1B). The results (not 
shown) indicated that neither salt had a significant 
effect on the intrinsic activity. The two salts had 
similar effects on the reconstitution efficiency, which 
was decreased by about  15%, 30%, and 45% at 5, 10, 
and 20 mM salt, respectively. However, they differed 
1.0~R.  
t . . . . .  
0.0 
0 5 10 15 20 
[salt] (raM) 
Fig. 5. Effects of NaC1 and KC1 on reconstituted transporters. 
Cholate-dispersed rat heart HSP membrane proteins were re- 
constituted into liposomes of egg lipids; human erythrocyte 
membrane proteins were reconstituted into liposomes of soy- 
bean lipids. Liposomes were prepared, reconstituted, and as- 
sayed in 10 mM Tris buffer plus the indicated concentration of 
salt. Circles, initial rate of stereospecific uptake of 0.2 mM glu- 
cose, estimated from uptake at 30 s; triangles, total stereospe- 
cific uptake, estimated from uptake at 30 min; squares, total 
liposome volume, estimated from uptake of L-glucose in 24 h. 
Filled symbols and solid lines, NaC1; open symbols and broken 
lines, KC1. Data plotted at 5, 10, and 20 mM and connected 
by lines are for heart ransporters ( ome points have been offset 
with respect o the x-axis for clarity). The six data points plot- 
ted at the far right are for erythrocyte transporters at 20 mM 
salt. Results were normalized to liposomes without added salt 
in the same experiments, and are means from two or three ex- 
periments. 
significantly in their effects on the l iposome size, as 
indicated by the L-glucose uptake (Fig. 5, squares). 
At 20 mM salt, the l iposomes prepared in KC1 had a 
3-fold higher volume than those prepared in NaC1. 
Similar experiments were carried out using eryth- 
rocyte transporters reconstituted using soybean lipids 
Table 2 
Effects of trypsin on reconstituted glucose transporters 
Sample Uptake vs. control 
30 s 2 min 5 min 20 min 
Heart 0.68+0.12 (n=5) 0.54 (0.54, 0.53) 0.69+0.12 (n=3) 
Basal adipocytes 0.29 (0.41, 0.17) 0.33 (0.34, 0.32) 
Insulin-treated adipocytes 0.46 (0.35, 0.57) 
Rat heart HSP membrane proteins were reconstituted into liposomes of egg lipids after cholate dispersal. HSP membrane proteins 
from basal or insulin-treated rat adipocytes were reconstituted without detergent treatment. After reconstitution, liposomes were incu- 
bated with TPCK-treated trypsin (0.02 mg/ml) for 20 min or more before assays were begun. Stereospecific uptake of 0.2 mM glucose 
in the indicated time was measured, and compared to that for liposomes not treated with trypsin. Results are means + S.E. (n = 3 or 
5), or means with individual values in parentheses (n= 2). 
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in the presence or absence of 20 mM salt (Fig. 5, 
data at far right). As in the heart experiments, the 
intrinsic activity was not affected by the added salt, 
and both salts decreased the reconstitution efficiency 
by about 50%. However, the decrease in volume with 
added NaC1 (48%) was only 1.5-fold larger than that 
with added KCI (32%) (squares). A single experiment 
for heart transporters reconstituted using soybean 
lipids and tested at 20 mM salt also showed smaller 
differences between NaC1 and KC1 than those shown 
for heart ransporters in Fig. 5. This suggests that the 
lipid type rather than the source of transporters was 
more important in determining the relative effects of 
NaC1 and KC1. 
4. Discussion 
4.1. Egg lipids vs. soybean lipids 
In the experiments summarized in Table 1, we 
found that the use of liposomes of egg lipids rather 
than soybean lipids increased the reconstituted ster- 
eospecific glucose uptake, and decreased the non-spe- 
cific uptake, for many types of samples. This im- 
proved the signal to noise ratio for reconstituted 
transport by as much as 5-fold. In general the effects 
were greater for detergent-treated membranes com- 
pared to untreated membranes of the same type. In- 
creased stereospecific uptake in 2 min with egg lipids 
could arise from greater reconstitution efficiency, 
greater liposome sizes, or a combination of both. 
Results with bovine heart plasma membranes indi- 
cated an effect on liposome size, while those with 
erythrocyte ghosts indicated an effect on reconstitu- 
tion efficiency. 
The fact that the egg lipids generally were more 
effective for detergent-treated than for untreated 
membranes suggests that a lipid component which 
assists in the reconstitution may be present in the 
native membranes, lost during detergent treatment, 
and then resupplied more readily by egg than by 
soybean lipids. In the case of the erythrocyte trans- 
porter, the purification procedure results in a reasso- 
ciation of the protein with membrane lipids, and the 
reconstitution again becomes insensitive to the choice 
of egg or soybean lipids. 
Phosphatidylethanolamine (PE), which makes up 
about 20% of the egg lipids (type IX-E) but only 
5-10% of the soybean lipids (data provided by 
Greg Wall, Technical Services, Sigma), could possi- 
bly be responsible for the differences. Reconstituted 
glucose transporters from LM cells were more active 
at higher ratios of PE to PC [24]. The two types of 
lipids also differ in their fatty acyl groups; the egg 
lipids have more palmitic, stearic, and oleic residues, 
while the soybean lipids are more enriched in linoleic 
residues. The egg lipids also have a much higher 
content of PC (60% vs. 15%), but we previously 
found that less activity was obtained with soybean 
lipids more enriched in PC [7]. 
We also found, in this study, considerable varia- 
tion among different lots of a single egg lipid product 
(type XV-E), and previously reported similar varia- 
tions among lots of soybean lipids (type II-S) [7]. 
Thus, investigators obtaining unsatisfactory econsti- 
tution results may wish to test multiple lots of a 
given lipid preparation. 
The results in Table 1 include various stages in the 
purification of the human erythrocyte transporter. 
Using the results for egg liposomes, the specific ac- 
tivity of the reconstituted alkaline-washed vesicles 
(400 ktl equilibrated in 2 min/mg protein) was about 
2.5-fold higher than both the ghosts (140 ktl/mg) and 
the Triton extract (160 pJ/mg), and was nearly as 
high as the purified transporter (440 ktl/mg). This 
suggests that a large amount of the transport activity 
is lost at the Triton extraction step. 
4.2. Effects of diacylglycerol 
The experiments shown in Fig. 1 were prompted 
by reports that exogenous diacylglycerol could stim- 
ulate glucose transport [15,16], and the suggestion 
that the direct interaction of DAG with glucose 
transporters could be part of the mechanism of ac- 
tion of insulin. Using data of Okamura et al. [25], the 
ratio of DAG to total lipid in rat ventricular tissue is 
about 0.24%. If higher levels occur in plasma mem- 
branes of cardiomyocytes, and these are increased 
further in response to insulin, contents on the order 
of several percent might be attained. While these 
levels of DAG produce significant effects on recon- 
stituted glucose transport activity (Fig. 1A), the cal- 
culated increase in the intrinsic activity of the trans- 
porter (Fig. 1B) is only about 25%. Such an effect 
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would be relatively small compared to that of trans- 
location. 
In contrast o the original report of Str~lfors [15], 
more recent studies from the same group [26] indi- 
cated that DAG does in fact cause translocation of 
GLUT4. Others (e.g., [27,28]) have also concluded 
that an increase in DAG in response to insulin is 
unlikely to activate glucose transport directly. More- 
over, Eckel and Reinauer [29] observed a decrease in 
DAG in insulin-treated cardiomyocytes. 
As reviewed by Zidovetski and Lester [30], long- 
chain (C12-C18) saturated iacylglycerols at levels 
such as we used (Fig. 1) destabilize the structure of 
lipid bilayers, enhancing the formation of the hexag- 
onal phase. Such effects have been correlated with 
activation of phospholipases and protein kinase C, 
which could be analogous to effects on the intrinsic 
activity of the reconstituted glucose transporters 
(filled circles, Fig. 1B). Formation of the hexagonal 
phase has also been associated with increased mem- 
brane fusion (e.g., [31]), which could explain the pro- 
duction of larger liposomes in the freeze-thaw proc- 
ess (triangles, Fig. 1A,B). This effect may be of 
practical importance, since transport is more readily 
measured in reconstituted liposomes having larger 
internal volumes. 
4.3. Effects of dipeptide 
As shown in Fig. 2, concentrations of the dipep- 
tide Cbz-Gly-Phe-NH2 below 1 mM inhibit reconsti- 
tuted transporters from heart (circles and solid line) 
much more strongly than those from erythrocytes 
(broken line). This suggests that GLUT4, the major 
isoform in heart, has a higher affinity for the dipep- 
tide (Ki of 0.1-0.2 mM) than does GLUT1 (Ki of 2.5 
mM). The inhibition of the heart transporters ap- 
pears to reach a maximum of less than 75%, possibly 
because their less sensitive GLUT1 component is 
only partially inhibited at the concentrations studied. 
The transport inhibitors forskolin, dipyridamole, and 
isobutylmethylxanthine also have higher affinity for 
GLUT4 than for GLUT1 [32]. 
Since adipocyte plasma membranes become more 
enriched in GLUT4 relative to GLUT1 upon insulin 
stimulation, differential sensitivity of GLUT1 and 
GLUT4 can explain the observation of Aiello et al. 
[17] that insulin-stimulated glucose transport in adi- 
pocytes is more sensitive than basal transport to in- 
hibition by the dipeptide. Using Ki values of 0.15 
mM and 2.5 mM for GLUT4 and GLUT1, respec- 
tively, a maximum inhibition of 100% for both iso- 
forms, and contents of GLUT4 of 69% in basal cells 
and 90% in insulin-stimulated cells [33], it can be 
calculated that 1 mM dipeptide would inhibit trans- 
port by 69% and 81% in basal and in insulin-stimu- 
lated cells, respectively. This agrees qualitatively with 
the values of 51% and 76% observed by Aiello et al. 
([17], Table I). 
Epand et al. [34] also observed a differential sensi- 
tivity of basal and insulin-stimulated a ipocyte trans- 
port to Cbz-Gly-Phe-NH2. However, the inhibition 
by the dipeptide was much more potent in this study 
(58% inhibition of insulin-stimulated uptake by 10 
~tM dipeptide) than in our studies or those of Aiello 
et al. [17]. 
In contrast o these results with mammalian glu- 
cose transporters, Booz and Bianchi, in studies of 
frog muscle, found that 1.5 mM Cbz-Gly-Phe-NH2 
inhibited basal, contraction-stimulated, and insulin- 
stimulated 3-O-methylglucose transport similarly 
[35]. Thus, GLUT1 and GLUT4 of frog may have 
similar affinities for the dipeptide, or the relative pro- 
portions of the two forms in the plasma membrane 
may not be altered by insulin or contraction. 
4.4. Effects of verapamil 
Cartee et al. [19] found that verapamil inhibited 
insulin- or hypoxia-stimulated methylglucose trans- 
port in skeletal muscle by a mechanism independent 
of its effects on calcium channels. It was proposed 
that the drug was either blocking translocation or 
inhibiting transporters directly. We found that recon- 
stituted glucose transporters (from either heart or 
erythrocytes) were not inhibited by verapamil, argu- 
ing against he latter. Montero et al. [36] observed 
that in chicken enterocytes, 2-deoxyglucose transport 
(which is Na+-independent) was unaffected by 200 
p.M verapamil. On the other hand, Vera et al. [37] 
reported that 100 ~tM verapamil produced 60% in- 
hibition of 2-deoxyglucose uptake by Xenopus oo- 
cytes expressing rat GLUT1. Possibly this was an 
effect of the drug on phosphorylation (which can 
be rate-determining for 2-deoxyglucose uptake [38]) 
rather than transport. 
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4. 5. Net and exchange flux of  GL UT1 and GL UT4 
As shown in Fig. 3, reconstituted rat heart trans- 
porters (mostly GLUT4) had a higher Km for zero- 
trans uptake (13 mM) than did human erythrocyte 
transporters (GLUT1) (1.6 mM). Fig. 4 shows that 
even higher kinetic parameters were obtained under 
equilibrium exchange conditions. However, experi- 
ments using variable salt concentrations showed 
that at least some of the differences between net 
and exchange flux for the reconstituted heart trans- 
porters were artifacts of the osmotic changes in the 
zero-trans experiments. Thus, the true Km for zero- 
trans flux may be higher than 13 mM. The Km ob- 
served for exchange (62 + 23 mM, Fig. 4) is not sig- 
nificantly different han that observed for reconsti- 
tuted erythrocyte transporters (35 + 4 mM [2]). 
The finding of a higher (net flux) or similar (ex- 
change) Km for GLUT4 compared to GLUT1 might 
be considered surprising in light of results using 3T3- 
L1 adipocytes [39] or exogenous GLUT1 and 
GLUT4 expressed in Xenopus oocytes [40,41], in 
which 3-12-fold lower Km values were observed for 
GLUT4 than for GLUT1. However, these studies all 
measured 3-O-methylglucose transport under equili- 
brium exchange conditions. 
In studies using glucose as a substrate [42,43], plas- 
ma membrane vesicles from insulin-stimulated or ex- 
ercised skeletal muscle (in which transporters would 
be mostly GLUT4) had exchange Km values of about 
20 mM, much higher than the exchange Km values 
for GLUT4 reported in [39-41] (2-7 mM). Another 
type of skeletal muscle plasma membrane vesicle 
preparation, containing GLUT4 but no detectable 
GLUT1, had a zero-trans uptake Km for glucose of 
16-18 mM [44]. NMR data from intact, insulin- 
stimulated muscle yielded an estimated Km of 17 
mM [45]. Thus, differences between our results and 
those of [39-41] may be due to the choice of sub- 
strate. 
Recently, Kasahara and Kasahara [46] expressed 
rat GLUT1 and GLUT4 in Saccharomyces cerevi- 
siae, reconstituted the proteins in liposomes, and as- 
sayed glucose transport. Under zero-trans conditions, 
GLUT4 had a Km of 12 mM, in excellent agreement 
with our value of 13 mM (Fig. 3A). GLUT1 had a 
much lower Km (3.5 mM), in qualitative agreement 
with our results for human GLUT1 (1.6 mM, Fig. 
3B). They also measured equilibrium exchange of 
glucose, obtaining values of 22 and 26 mM for 
GLUT4 and GLUT1, respectively. These also agree 
qualitatively with our finding of higher Km values 
under exchange conditions for both isoforms. 
4.6. Effects of trypsin 
As shown by the results in Table 2, reconstituted 
GLUT4 transporters from rat heart and adipocytes 
are partially resistant to trypsin treatment, as is the 
case for reconstituted GLUT1 [2,3]. This suggests 
that GLUT4, like GLUT1 [23], has trypsin-sensitive 
sites present at the cytoplasmic domain; reconstitu- 
tion with a scrambling of orientations would make 
about half of the transporters susceptible to external 
trypsin [2,3]. Eight sites of trypsin cleavage, all cyto- 
plasmic, have been identified for GLUT1 [47]. For 
six of these, arginine is either conserved in the cor- 
responding position of GLUT4, or else lysine in 
GLUT1 is replaced by arginine in GLUT4. Thus, it 
seems likely that the cytoplasmic domain of GLUT4 
should also be sensitive to trypsin. 
Experiments with adipocytes demonstrated cleav- 
age of GLUT4 by extracellular trypsin [48]. How- 
ever, in this study both the trypsin concentration (1 
mg/ml vs. 0.02 mg/ml) and temperature (37 ° vs. room 
temperature) for treatment were higher than in our 
experiments. The cleavage observed in [48] may 
therefore occur at sites which are less susceptible 
than the cytoplasmic sites. 
4. 7. Effects of NaCl and KCI 
The experiments shown in Fig. 5 were aimed at 
determining levels of salt which could reduce osmotic 
shrinking at the initiation of transport assays, while 
still providing suitable reconstituted transport activ- 
ity. We observed ecreases in the activity when the 
liposomes were prepared and reconstituted with 
heart transporters in the presence of 5-20 mM 
NaC1 or KC1 (Fig. 5). Calculations indicated that 
the added salts did not reduce the intrinsic activity, 
which is as expected for a protein which physiologi- 
cally operates at much higher ionic strength. Rather, 
the inhibitory effects appeared to be related to the 
fusion of liposomes with transporter-containing 
membranes and with each other. Previously, Pick 
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[49] reported that salts decrease the sizes of freeze- 
thaw liposomes, with changes imilar to those we 
observed (Fig. 5, squares). 
The data of Fig. 5 also show that for a given salt 
concentration, greater econstituted transport activ- 
ity was obtained using KC1 (open symbols) rather 
than NaC1 (filled symbols). This difference appeared 
to be due primarily to differences in liposome sizes 
(squares). Possibly some of the smaller liposomes are 
not retained on the Millipore filters, contributing to 
the decrease in the measured transport activity, and 
accentuating the differences between the effects of 
NaCI and KCI. In the original report of the freeze- 
thaw reconstitution of glucose transporters, Kasa- 
hara and Hinkle [1] observed only a 23% decrease 
in the initial rate of reconstituted transporters when 
150 mM KC1 was used, a much smaller inhibitory 
effect than we observed (Fig. 5). 
Oka and MacDonald [50] prepared sonicated lip- 
osomes without salt, added salt prior to a freeze- 
thaw step, and dialyzed away the salt. This formed 
giant liposomes, which were much larger for KC1 
than for NaC1. Thus, in our experiments, an ability 
of KC1 to promote liposome aggregation may have 
offset its inhibitory effects to a greater extent han for 
the case of NaCI. Alternatively, Oka and MacDon- 
ald [50] noted differences between hydration of Na ÷ 
and K + ions as salt solutions are frozen; such differ- 
ences might influence the freeze-thaw process. 
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